當(dāng)前位置:布魯克磁共振事業(yè)部>>技術(shù)文章>>核磁共振發(fā)現(xiàn)HIV疫苗靶點(diǎn)為α螺旋
核磁共振發(fā)現(xiàn)HIV疫苗靶點(diǎn)為α螺旋
近期的一項(xiàng)研究使用核磁共振(NMR)技術(shù)來測(cè)定HIV疫苗抗體的一種已知靶向肽的三維結(jié)構(gòu)。該研究報(bào)告揭示了一種動(dòng)態(tài)α螺旋結(jié)構(gòu),并指出該結(jié)構(gòu)可能是HIV疫苗發(fā)揮效力的基礎(chǔ)。
Aiyegbo, Mohammed S., Evgeny Shmelkov, Lorenzo Dominguez, Michael Goger, Shibani Battacharya, Allan C. Decamp, Peter B. Gilbert, Phillip W. Berman, and Timothy Cardozo. “Peptide Targeted by Human Antibodies Associated with HIV Vaccine-Associated Protection Assumes a Dynamic ?±-Helical Structure." Plos One 12.1 (2017)
Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. NEngl J Med. 2009; 361(23):2209–20.
Zolla-Pazner S, deCamp AC, Cardozo T, Karasavvas N, Gottardo R, Williams C, et al. Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial. PLoS One. 2013; 8(1).